# Extension Study to Evaluate Safety and Tolerability of Peginesatide for Long-Term Treatment of Anemia in Participants With CKD (EU)

> **NCT00453973** · PHASE2 · TERMINATED · sponsor: **Affymax** · enrollment: 114 (actual)

## Conditions studied

- Chronic Renal Failure
- Chronic Kidney Disease
- Anemia

## Interventions

- **DRUG:** peginesatide
- **DRUG:** peginesatide

## Key facts

- **NCT ID:** NCT00453973
- **Lead sponsor:** Affymax
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-11
- **Primary completion:** 2009-09
- **Final completion:** 2009-09
- **Target enrollment:** 114 (ACTUAL)
- **Why stopped:** Due to more robust long-term data generated in other active-controlled studies
- **Last updated:** 2012-06-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00453973

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00453973, "Extension Study to Evaluate Safety and Tolerability of Peginesatide for Long-Term Treatment of Anemia in Participants With CKD (EU)". Retrieved via AI Analytics 2026-09-07 from https://api.ai-analytics.org/clinical/NCT00453973. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*